ArticleJournal of nanobiotechnology2022

Huc-MSC-derived exosomes modified with the targeting peptide of aHSCs for liver fibrosis therapy.

Yan Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.